The future of German agricultural trading group BayWa is now almost entirely in the hands of its two main banks. DZ Bank and HVB must decide whether to extend a critical standstill agreement until autumn 2026. Without their consent, the StaRUG insolvency plan finalized in May 2025 loses its legal foundation, leaving the company with no operational basis. This looming deadline overshadows every other element of a restructuring effort that is buckling under legal scrutiny and a massive funding shortfall.
Prosecutors are intensifying the pressure. The Munich I public prosecutor’s office is investigating former CEOs Klaus Josef Lutz and Marcus Pöllinger on suspicion of breach of trust and misrepresentation in the 2023 financial statements. Searches were conducted in January. All accused are presumed innocent. Germany’s financial watchdog, BaFin, has issued a formal reprimand, stating BayWa omitted crucial details about a billion-euro loan and refinancing risks for a €500 million bond in its 2023 management report.
This regulatory action has
Financially, the company’s position remains precarious. The original restructuring plan has collapsed. It was built on selling a 51% stake in the renewable energy subsidiary BayWa r.e., expected to raise €1.7 billion. That strategy is now defunct due to the US “One Big Beautiful Bill Act,” which significantly cut subsidies for renewable energy. This is a major blow, as BayWa r.e. sold over 530 megawatts of project capacity in the US in 2024. Without state support, the unit’s attractiveness to buyers has plummeted.
Should investors sell immediately? Or is it worth buying BayWa?
Asset sales are progressing slowly. So far, deals including the Cefetra sale have reduced debt by €1.3 billion—just under a third of the total €4 billion target. A cash injection of approximately €107 million from the Cefetra transaction is due at the end of April, which management is using as leverage in talks with the banks. The cooperative owners have already injected about €550 million via capital increases and loans over the past two years and wrote down 60% of a €220 million promissory note in the 2024 accounts.
Attention has turned to the sale of New Zealand fruit trader T&G Global, in which BayWa holds a nearly 74% stake. The business, with brands like Envy and Jazz, returned to profitability in 2024 with a net profit of $16 million on revenue of $1.3 billion. However, the process is being slowed by minority shareholder Joy Wing Mau Group, which holds nearly 20%. Even if sold, the expected proceeds of around €300 million would barely make a dent in the remaining €2.7 billion funding gap.
Investors are navigating in the dark. The audited group financial statements for 2025 are delayed due to complex revaluations in the energy division and are not expected until the fourth quarter of 2026 at the earliest. Management has already withdrawn its 2026 forecast and lowered its 2027 EBITDA target to around €140 million. The supervisory board has tightened controls, lowering the threshold for transactions requiring its approval from €200 million to €50 million, and three members have recently departed.
The stock price reflects the profound uncertainty. Although it gained over 7% in a recent session to €14.35, the share is down about 14% since the start of the year and trades more than 33% below its 52-week high. The company aims to focus on four core areas and reduce group sales to about €10 billion by the end of 2028. Whether it gets that chance depends overwhelmingly on a single decision from its lenders this autumn.
Ad
BayWa Stock: Buy or Sell?! New BayWa Analysis from April 22 delivers the answer:
The latest BayWa figures speak for themselves: Urgent action needed for BayWa investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 22.
BayWa: Buy or sell? Read more here...
